Using Molecular Targets to Predict and Treat Aortic Aneurysms

Xiaonan Zhou1,2, Gang Liu1,2, Hao Lai1,2

  • 1Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.

Insights

Aortic aneurysms require better prediction methods beyond size. Molecular targets show promise for early diagnosis, risk assessment, and treatment of this life-threatening vascular disease.

Area of Science:

  • Vascular Biology
  • Cardiovascular Medicine
  • Molecular Medicine

Background:

  • Aortic aneurysms are serious vascular conditions with high morbidity, often necessitating surgery.
  • Current diagnostic standards based on aortic size are insufficient for predicting disease progression and complications.
  • Understanding aneurysm pathophysiology is crucial for improved prediction and treatment strategies.

Purpose of the Study:

  • To review current clinical prediction standards for aortic aneurysms.
  • To discuss molecular targets for predicting and treating aortic aneurysms.
  • To highlight molecules with potential for early diagnosis and risk stratification.

Main Methods:

  • Literature review of current clinical prediction standards.
  • Analysis of studies on aortic aneurysm pathophysiology.
  • Identification and discussion of relevant molecular targets.

Main Results:

  • Current methods using aortic diameter are inadequate predictors.
  • Specific molecules are implicated in aneurysm development and progression.
  • Several molecular targets show potential for early detection and risk assessment.

Conclusions:

  • There is a critical need for improved prediction of aortic aneurysm progression.
  • Molecular targets offer a promising avenue for enhanced diagnostic accuracy and risk stratification.
  • Further research into molecular mechanisms can guide targeted therapies for aortic aneurysms.